| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (Right to Buy) | 25k | $1.57 | $39.2k | | 06/14/2023 |
| 03/29/2023 | CytomX Therapeutics, Inc. | CTMX | Purchase | Common Stock | 5k | $1.55 | $7.8k | | 03/29/2023 |
| 06/23/2022 | NextCure, Inc. | NXTC | Grant | Stock Option (Right to Buy) | 14.2k | $4.77 | $68k | | 06/23/2022 |
| 06/17/2022 | Gritstone bio, Inc. | GRTS | Grant | Stock Option (Right to Buy) | 19k | $2.22 | $42.2k | | 06/17/2022 |
| 06/15/2022 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (Right to Buy) | 25k | $1.72 | $43k | | 06/15/2022 |
| 06/24/2021 | NextCure, Inc. | NXTC | Grant | Stock Option (Right to Buy) | 14.2k | $8.21 | $117k | | 06/24/2021 |
| 06/18/2021 | Gritstone bio, Inc. | GRTS | Grant | Stock Option (Right to Buy) | 19k | $9.86 | $187.3k | | 06/18/2021 |
| 06/16/2021 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (Right to Buy) | 20k | $7.13 | $142.6k | | 06/16/2021 |
| 06/18/2020 | Gritstone bio, Inc. | GRTS | Grant | Stock Option (Right to Buy) | 12.5k | $6.66 | $83.2k | | 06/18/2020 |
| 06/17/2020 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (Right to Buy) | 20k | $8.35 | $167k | | 06/17/2020 |
| 06/11/2020 | NextCure, Inc. | NXTC | Grant | Stock Option (Right to Buy) | 14.2k | $24.13 | $343.9k | | 06/11/2020 |
| 09/12/2019 | Gritstone bio, Inc. | GRTS | Grant | Stock Option (Right to Buy) | 15.9k | $10.20 | $162.6k | | 09/12/2019 |
| 06/19/2019 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (Right to Buy) | 14k | $11.31 | $158.3k | | 06/19/2019 |
| 06/13/2019 | NextCure, Inc. | NXTC | Grant | Stock Option (Right to Buy) | 22k | $15.57 | $342.5k | | 06/13/2019 |
| 05/01/2019 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (right to buy) | 28k | $9.35 | $261.8k | | 05/01/2019 |